SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Annual Wellness Visit, Subsequent — George H. W. Bush

PatientGeorge H. W. Bush
Date of birth1959-06-12
IdentifiersMRN HR-ML018-SYN; SSN (made up) 000-18-7245
Document date2026-10-16
AuthorDouglas Whitford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Subsequent annual wellness visit; no new complaints. [S]

History of Present Illness

Mr. Bush is a 67-year-old man who returns for his subsequent annual wellness visit five weeks after his four-month review. He had his initial annual wellness visit with his previous primary care clinician last year. Since the spring he has had paroxysmal atrial fibrillation triggered by Graves' disease, treated with radioactive iodine, and is now on levothyroxine for the hypothyroidism that followed. He completed the health risk assessment before the visit. He takes levothyroxine 100 mcg each morning before breakfast, five weeks after the dose was raised, and has missed no doses. Metoprolol and apixaban were stopped at the last visit after a 14-day monitor showed sinus rhythm throughout; he has had no palpitations, lightheadedness, or breathlessness since. He runs three miles four days a week. He has no new concerns. [S]

ElementDetail
VisitSubsequent annual wellness visit
Safety eventsOne hospital stay this year, for atrial fibrillation in the spring; no falls or emergency visits since
MedicinesLevothyroxine 100 mcg daily; no over-the-counter medicines or supplements
Active conditionsParoxysmal atrial fibrillation in sinus rhythm since the spring; Graves' disease treated with radioactive iodine; hypothyroidism on levothyroxine
Functional statusIndependent in all activities and instrumental activities of daily living; running again

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthVery good
PsychosocialLives with his spouse; close family and friends; busy and satisfying work; no loneliness
TobaccoNever used tobacco
Alcohol and drugsA glass of wine with dinner now and then (AUDIT-C 1); no other drug use
Physical activityRuns three miles four days a week and walks most days, about 200 minutes a week in all
NutritionRegular meals; weight back to his usual after the weight loss in the spring
SleepSix to seven hours a night; no snoring reported; not sleepy in the daytime
Activities of daily livingIndependent
Instrumental activities of daily livingIndependent
Home safetySmoke detectors working; no loose rugs; handrails on the stairs
FallsNo falls this year
Hearing and visionNo hearing concern; reading glasses
MemoryNo concerns

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable over the past two months; no fatigue, heat or cold intolerance, or night sweats
EyesNegativeNo eye pain, redness, grittiness, bulging, or double vision
Ears, nose, mouth, and throatNegativeNo hearing loss, hoarseness, or trouble swallowing
CardiovascularNegativeNo palpitations, chest pain, lightheadedness, or ankle swelling
RespiratoryNegativeNo cough or breathlessness when running
GastrointestinalNegativeNo constipation, diarrhea, or blood in the stool
GenitourinaryNegativeNo urinary symptoms
MusculoskeletalNegativeNo joint pain that limits running; no cramps
IntegumentaryNegativeNo dry skin, hair loss, or new skin lesions
NeurologicalNegativeNo tremor, weakness, numbness, or memory change
PsychiatricNegativeMood good; sleeping well; PHQ-2 score 0
EndocrineNegativeNo thirst or frequent urination
HematologicNegativeNo easy bruising or bleeding since stopping apixaban

13 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metoprolol succinate extended-release 50 mg oral tablet, one tablet by mouth daily (started in hospital)One tablet each morningOral route2026-05-05 to 2026-07-17stoppedS
Metoprolol succinate extended-release 25 mg oral tablet, one tablet by mouth daily (taper)One tablet each morning for eight weeks, then stopOral route2026-07-17 to 2026-09-11stoppedS
Apixaban 5 mg oral tablet, one tablet by mouth twice daily (started in hospital)One tablet twice dailyOral route2026-05-05 to 2026-09-11stoppedS
Methimazole 10 mg oral tablet, two tablets (20 mg) by mouth dailyTwo tablets once daily; stop three days before radioactive iodineOral route2026-05-08 to 2026-05-26completedS
Levothyroxine 75 mcg oral tablet, one tablet by mouth daily before breakfastOne tablet on an empty stomach 30 to 60 minutes before breakfastOral route2026-07-17 to 2026-09-11stoppedS
Levothyroxine 100 mcg oral tablet, one tablet by mouth daily before breakfastOne tablet on an empty stomach 30 to 60 minutes before breakfastOral route2026-09-11activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-16Body height188cmS
2026-10-16Body weight90.8kgS
2026-10-16Body mass index (BMI) [Ratio]25.7kg/m2S
2026-10-16Systolic blood pressure128mm[Hg]S
2026-10-16Diastolic blood pressure78mm[Hg]S
2026-10-16Heart rate68/minS
2026-10-16Respiratory rate14/minS
2026-10-16Body temperature36.7CelS
2026-10-16Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-16Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-16Total score [Mini-Cog]5{score}S
2026-10-16Total score [AUDIT-C]1{score}S
2026-10-16Thyrotropin [Units/volume] in Serum or Plasma2.6m[IU]/L0.4-4 mIU/LNormalS
2026-10-16Cholesterol [Mass/volume] in Serum or Plasma186mg/dL<=200 mg/dLNormalS
2026-10-16Cholesterol in HDL [Mass/volume] in Serum or Plasma58mg/dL>=40 mg/dLNormalS
2026-10-16Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation108mg/dL<=129 mg/dLNormalS
2026-10-16Triglyceride [Mass/volume] in Serum or Plasma100mg/dL<=149 mg/dLNormalS
2026-10-16Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS

Physical Exam

Vital signs recorded on 2026-10-16; see the Vital Signs section. [S]

SystemFinding
ConstitutionalTall, fit, and alert; weight 90.8 kg, BMI 25.7
EyesNo lid lag, lid retraction, or proptosis; eye movements full
EarsCanals clear; whispered-voice test passed in both ears
NeckThyroid smaller than in the spring, non-tender, without nodules; no bruit
CardiovascularRegular rhythm at 68 per minute; no murmur; no edema
RespiratoryClear to auscultation
AbdomenSoft and non-tender; no masses
MusculoskeletalTimed Up and Go 8 seconds
NeurologicalNo tremor; reflexes normal with normal relaxation; Mini-Cog 5 of 5
PsychiatricEuthymic and engaged; judgment and insight intact
SkinWarm and normal in texture; no suspicious lesions

Problems

ProblemClinical statusVerificationCodeProvenance
Paroxysmal atrial fibrillation, first detected four days before intake while running, triggered by hyperthyroidism; CHA2DS2-VASc 1; synthetic modern episode linked to his documented atrial fibrillationactiveconfirmed I48.0S — Synthetic modern classification of a documented arrhythmia.
Graves' disease with hyperthyroidism; synthetic modern diagnosis linked to his documented Graves' diseaseactiveconfirmed E05.00S — Synthetic modern diagnosis confirmed by thyroid tests and TSH receptor antibody; the historical diagnosis is D.
Hypothyroidism after radioactive iodine, on levothyroxine replacementactiveconfirmed E89.0S — Synthetic modern diagnosis linked to his documented hypothyroidism and lifelong thyroid hormone.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, this seasonCompleted todayHigh-dose vaccine given today
Tetanus, diphtheria, and pertussis boosterCompleted todayTdap given today; no dose on record in the past ten years
Pneumococcal vaccineUp to datePCV20 given two years ago; no further doses needed
Recombinant zoster vaccineUp to dateTwo-dose series completed
COVID-19 vaccine, this seasonDueRecommended at 65 and older; he will get it at the pharmacy
RSV vaccineNot indicatedRecommended at 75 and older, and from 50 with conditions that raise risk, such as heart failure or coronary disease; he has neither. Review at 75
Colorectal cancer screeningUp to dateColonoscopy on file within the recommended interval; the next one is due as set by his gastroenterologist's report
Prostate cancer screeningDeclinedShared decision-making about PSA testing at 55 to 69; after discussion of benefits and harms he chose not to be tested this year. Revisit yearly until 70
Abdominal aortic aneurysm and lung cancer screeningNot indicatedNever used tobacco
Cholesterol screening and statin decisionCompleted todayTotal cholesterol 186, HDL 58, LDL 108, triglycerides 100 mg/dL. Ten-year risk about 9 percent with no risk factor, so a statin is not recommended; repeat in five years
Diabetes screeningCompleted todayHbA1c 5.4 percent; overweight adult aged 35 to 70; repeat in three years
Hepatitis C screeningOrderedOne-time screening recommended for adults 18 to 79; no result on record; drawn with his consent today
Depression screeningCompleted todayPHQ-2 score 0
Alcohol misuse screeningCompleted todayAUDIT-C score 1; advised to keep to no more than one drink a day, since alcohol can trigger atrial fibrillation
Cognitive assessmentCompleted todayMini-Cog 5 of 5
Falls preventionCompleted todayTimed Up and Go 8 seconds; no falls; regular running and walking
HearingCompleted todayWhispered-voice test passed in both ears
Eye examinationDueComprehensive eye examination every one to two years at 65 and older; none on record this year, and Graves' disease is a reason to look for eye involvement; he will book it

Immunizations given today: High-dose influenza vaccine, 2026-2027 season; Tdap vaccine [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, atrial fibrillation and hypothyroidism monographs (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: COVID-19 vaccine at the pharmacy. Hepatitis C result to be reviewed when back. Eye examination to be booked. TSH in six months. Next annual wellness visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying active, keeping working, and being told plainly about his health so he can make his own decisions. He chose not to record specific treatment preferences today. The plan will be revisited yearly and with any change in his health. [S]